Back to News
Market Impact: 0.25

Best Stock to Buy Right Now: Target vs. Altria

MOTGTNFLXNVDANDAQ
Consumer Demand & RetailCapital Returns (Dividends / Buybacks)Company FundamentalsManagement & GovernanceInterest Rates & YieldsCorporate EarningsInvestor Sentiment & Positioning
Best Stock to Buy Right Now: Target vs. Altria

Altria (MO) carries a high 7.3% dividend yield but faces persistent structural decline in its cigarette business—smokeable products are ~90% of revenue, cigarettes account for 97% of smokeable volume, cigarette volumes fell 8.2% YoY in Q3 2025 and Marlboro volume declined 11.7% (Marlboro = 85% of cigarette volume)—and Altria has taken large write-downs on failed vape and marijuana investments; its payout ratio is near 80%. By contrast, Target (TGT) yields ~4.5%, reported Q3 2025 same-store sales down 2.7% and overall sales down 1.5%, but management has installed a new CEO and strategic changes and Target’s dividend payout ratio (~55%) and long dividend-growth track record suggest greater resilience, making Target the preferred pick over Altria for income-focused investors.

Analysis

Market structure: Consumers rotating toward discounters (WMT, DLTR) and private-label channels directly benefits low-price retailers and squeezes premium-focused Target (TGT); tobacco incumbents (MO) face secular volume decline (cigarette volumes -8.2% YoY, Marlboro -11.7%) that steadily erodes pricing power and cashflow. Higher-yield staples like MO act as bond proxies; rising dividend risk will likely widen credit spreads for tobacco names and lift options implied vols, while retailers’ cyclicality will show up in consumer discretionary flows and FX-exposed sales via cross-border tourists. Risk assessment: Tail risks for MO include aggressive federal/state flavor bans, excise-tax shocks, or another failed big-ticket strategic pivot leading to >20% EBITDA impairment within 12–24 months; for TGT, a sharper consumer squeeze (SSS down >5% for two consecutive quarters) or execution errors under new CEO could force margin cuts. Immediate (days) risk is volatility around earnings/holiday comps; short-term (weeks–months) is a holiday-season SSS surprise; long-term (years) is secular decline in smoking versus successful alternatives adoption. Hidden dependencies include Altria’s balance-sheet leverage to legacy tobacco cashflows and Target’s inventory cadence vs. promotional cadence. Trade implications: Favor asymmetric exposure: buy TGT equity and income overlay (covered calls) and use short-duration put protection around two upcoming earnings/holiday prints; size 2–3% portfolio initial long, add on 7–10% price weakness. For MO, prefer options or small short exposure — e.g., buy 6–12 month put spreads sizing 0.5–1% notional to express dividend-cut risk rather than outright large short. Implement a market-neutral pair: long TGT / short MO equal-dollar (1–2% each) to capture divergence; rotate into discounters (WMT, DLTR) tactically on evidence of sustained share gains. Contrarian angles: Consensus overweights MO yield without pricing cigarette secular decline — a ~80% payout ratio leaves little buffer vs. a 5–10% further volume squeeze; reaction may be underdone. Conversely, TGT’s sell-off may be overdone if management execution stabilizes margins and SSS normalize; historical parallels: retailers that rebalanced assortment/price (e.g., post-2015) recovered within 4–8 quarters. Unintended consequence: a large MO dividend cut could push tobacco suppliers and muni-exposed issuers’ spreads wider, creating cross-asset dislocations to exploit with credit pairs.